Study Stopped
Early termination d/t overlap with a new, extended protocol study.
"No-Touch" Radiofrequency Ablation for Small Hepatocellular Carcinoma (≤ 3cm): A Prospective Multicenter Study
1 other identifier
interventional
5
1 country
1
Brief Summary
This study is a prospective multicenter study of the duration of treatment, the success rate, the frequency of complications, and the local recurrence rate of 12 months when Radio-frequency ablation therapy is performed for the treatment of HCC using the 'No touch' technique as a combined high-frequency transmission mode with Octopus electrodes. It aims to evaluate through. In addition, the results obtained from this prospective study were as follows: 1) Patients who underwent Radio-frequency ablation therapy by puncturing an existing tumor, and 2) Patients who underwent microwave ablation during the study period. The secondary goal is to evaluate which method is more effective in reducing the treatment time and recurrence rate compared to.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2019
CompletedFirst Submitted
Initial submission to the registry
March 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2021
CompletedFirst Posted
Study publicly available on registry
March 18, 2021
CompletedMarch 18, 2021
March 1, 2021
1.9 years
March 31, 2020
March 16, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Local tumor progression (LTP) rate
No. of participants with LTP/ No. of participants receiving RFA
12 months after RFA
Secondary Outcomes (2)
Intrahepatic distant recurrence (IDR) rate
12 months after RFA
Complication rate
12 months after RFA
Study Arms (1)
No touch radiofrequency ablation
EXPERIMENTALA total of 150 patients who have decided to participate in the study will be included, and prospective study will be performed to these patients for radio-frequency ablation using octopus electrodes, combined high-frequency transmission mode, and the 'No touch' technique.
Interventions
"No-Touch" Radiofrequency Ablation Using Octopus Electrodes and Combined RF Energy Delivery Mode
Eligibility Criteria
You may qualify if:
- Agree to the protocol's requirements and submit a consent form
- years old-85 years old
- Child-Pugh Class A or B7
- Among patients with cirrhosis, patients with hepatocellular carcinoma having a size of 1 cm-3 cm suspected of MDCT or MRI performed within 60 days are considered for radio-frequency ablation
- Patients who do not have a history of treatment for previous hepatocellular carcinoma, or who have a history of treatment for previous hepatocellular carcinoma, if recurrence has not been confirmed for at least 2 years after treatment
You may not qualify if:
- the number of liver tumors is 3 or more
- the maximum size of the tumor exceeds 3 cm
- diffuse infiltrative type
- the tumor adheres to the portal vein or hepatic vein or biliary tract of 5 mm or more
- patients with previous medical history of hepatocellular cancer who have recurrent hepatocellular cancer within 2 years
- the tumor is not visible even under CEUS-fusion image guidance
- Child-Pugh class B8 or C
- in case of invasion of liver vessels due to malignant hepatocellular carcinoma
- severe coagulopathy
- multiple distant metastasis
- the situation where the probability of obtaining appropriate data suitable for the research purpose is very low
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seoul National University Hospitallead
- Samsung Medical Centercollaborator
- Chosun University Hospitalcollaborator
Study Sites (1)
Seoul National University Hospital
Seoul, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
Jeong Min Lee, MD
Seoul National University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 31, 2020
First Posted
March 18, 2021
Study Start
April 1, 2019
Primary Completion
March 10, 2021
Study Completion
March 10, 2021
Last Updated
March 18, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share